Zoono Group Stock

Zoono Group EBITDA per Employee

The EBITDA per Employee of Zoono Group (ZNO.AX) as of Aug 5, 2026 is -1.80 M NZD. In the previous year, EBITDA per Employee was -4.31 M NZD — a change of -58.33% (higher).

EBITDA per Employee

-1.80 MNZD

YoY

-58.33%

Last updated:

EBITDA per Employee of Zoono Group is 2026 -1.80 M NZD. EBITDA per Employee of Zoono Group was 2025 -4.31 M NZD. It decreases by -58.33% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Zoono Group Stock analysis

What does Zoono Group do? The Zoono Group Ltd is a globally operating company that develops and distributes antimicrobial solutions. The company was founded in New Zealand in 2009 and now has branches and distribution partners in Australia, USA, Canada, Europe, Asia, and South Africa. The business model of Zoono is based on the development and marketing of antimicrobial solutions for use in various industries, such as healthcare, food industry, animal husbandry, and public buildings. The goal of Zoono is to provide a safe and effective alternative to conventional cleaning and disinfection methods. Zoono's products contain special molecules that adhere to surfaces and form a barrier against bacteria, viruses, fungi, and algae. Some of Zoono's products include hand disinfectants, surface disinfectants, air purifiers, and pet care products. The company places a strong emphasis on ensuring that these products are non-toxic, biodegradable, and environmentally friendly. Zoono's solutions have already proven themselves in various industries. For example, they are successfully used in the food industry to prevent the growth of bacteria and mold. The products are also used in healthcare settings because of their long-lasting effectiveness, reducing the risk of infections. In addition to antimicrobial solutions, Zoono also offers consulting services. The company develops individual solutions for customers and adapts the products to meet specific requirements and needs. Thanks to the high effectiveness of their products, extensive network of partners and customers, and constant innovation of new solutions, Zoono has established itself as a successful and forward-thinking company in the industry. In conclusion, the Zoono Group Ltd is an innovative and internationally operating company specializing in the development and marketing of antimicrobial solutions. Their business model is based on the development of safe and effective alternatives to conventional cleaning and disinfection methods. Thanks to the high effectiveness of their products and extensive network of partners and customers, Zoono has established itself as a leading provider in the industry. Zoono Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zoono Group stock

EBITDA per Employee of Zoono Group is -1.80 M NZD in 2026.

EBITDA per Employee of Zoono Group changed from -4.31 M NZD to -1.80 M NZD, representing a -58.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Zoono Group since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's NZD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Zoono Group historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Workforce — Zoono Group

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Zoono Group